These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2416331)

  • 1. Tofisopam and midazolam: differences in clinical effects and in changes of CSF monoamine metabolites.
    Hovi-Viander M; Kanto J; Scheinin H; Scheinin M
    Br J Clin Pharmacol; 1985 Nov; 20(5):492-6. PubMed ID: 2416331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF-amine metabolites in depression, dementia and in controls.
    Gjerris A; Werdelin L; Gjerris F; Sørensen PS; Rafaelsen OJ; Alling C
    Acta Psychiatr Scand; 1987 Jun; 75(6):619-28. PubMed ID: 2441573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
    Odink J; Kärkelä J; Thissen JT; Marnela KM
    Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid monoamine metabolites and neuropeptides in patients with panic disorder.
    Lepola U; Jolkkonen J; Pitkänen A; Riekkinen P; Rimón R
    Ann Med; 1990; 22(4):237-9. PubMed ID: 1701091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
    Beckmann H; Waldmeier P; Lauber J; Gattaz WF
    J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF monoamine metabolism in patients with tardive dyskinesia: effect of oxypertine and hydroxyzine pamoate.
    Akiyama K; Nagao T; Yamamoto M; Fujimoto A; Ebara T; Sato M; Otsuki S
    Folia Psychiatr Neurol Jpn; 1983; 37(2):129-35. PubMed ID: 6200411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine metabolites in ventricular CSF of children with posterior fossa tumors: correlation with tumor histology and cognitive functioning.
    Varela M; Alexiou GA; Liakopoulou M; Papakonstantinou E; Pitsouni D; Alevizopoulos GA
    J Neurosurg Pediatr; 2014 Apr; 13(4):375-9. PubMed ID: 24559277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
    Malm J; Kristensen B; Ekstedt J; Wester P
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1026-33. PubMed ID: 7522267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal reflexes and the concentrations of 5-HIAA, MHPG, and HVA in lumbar cereborspinal fluid after spinal lesions in man.
    Ashby P; Verrier M; Warsh JJ; Price KS
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1191-200. PubMed ID: 1011029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
    Sunderland T; Tariot PN; Cohen RM; Newhouse PA; Mellow AM; Mueller EA; Murphy DL
    Psychopharmacology (Berl); 1987; 91(3):293-6. PubMed ID: 2436247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine metabolite levels in rat CSF: kinetic studies.
    Scheinin H; Scheinin M
    Pharmacol Toxicol; 1987 Sep; 61(3):167-71. PubMed ID: 2446306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
    Kärkelä J; Scheinin M
    J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study.
    Oxenstierna G; Edman G; Iselius L; Oreland L; Ross SB; Sedvall G
    J Psychiatr Res; 1986; 20(1):19-29. PubMed ID: 2423688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.